West Nile Fever
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Vaccine
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
SanofiChimeriVax-WN02 vaccine
Allergy TherapeuticsVRC-WNVDNA020-00-VP
Sarepta TherapeuticsAVI-4020 Injection
Clinical Trials (3)
Total enrollment: 559 patients across 3 trials
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults
Start: Oct 2008Est. completion: Dec 2009479 patients
Phase 2Completed
Phase I Study of West Nile Virus Vaccine
Start: Mar 2006Est. completion: Dec 200730 patients
Phase 1Completed
An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Start: Nov 2004Est. completion: Nov 200450 patients
Phase 1Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.